Translate Bio, Inc.

Biotechnology company · Lexington, Massachusetts, United States

Translate Bio, Inc. is a biotechnology company headquartered in Lexington, Massachusetts, United States. Its earliest recorded incorporation is in 2016. It has reported private securities offerings to the US SEC, most recently $47 million sold in a notice filed in 2019.

Profile compiled from public records. Is this your company? Request a correction or update

Translate Bio at a glance

Typebiotechnology company

HeadquartersLexington, Massachusetts, United States

Earliest incorporation on record2016

SEC industryBiological Products, (No Diagnostic Substances)

SEC CIK1693415

What does Translate Bio do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $47.5 million sold (2019).

Frequently asked questions about Translate Bio

Where is Translate Bio headquartered?

Translate Bio, Inc. is headquartered in Lexington, Massachusetts, United States.

What does Translate Bio do?

Translate Bio, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

When was Translate Bio founded?

The earliest incorporation on record for Translate Bio, Inc. is in 2016, according to public company registers.

Similar companies

Agenus IncLexington, Massachusetts, United States
Voyager Therapeutics, Inc.Lexington, Massachusetts, United States
Curis IncLexington, Massachusetts, United States
Biomedical Development CorpLexington, Kentucky, United States
LogicBio Therapeutics, Inc.Lexington, Massachusetts, United States
Oasis Pharmaceuticals, LLCLexington, Massachusetts, United States
LayerBio, Inc.Lexington, Massachusetts, United States
Hera Testing Laboratories, Inc.Lexington, Kentucky, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences